Patency of saphenous veins used for aortocoronary bypass grafting: effects of platelet-derived mediators.
Chiavarelli
M
M
Fabi
F
F
Chiavarelli
R
R
Toscano
M
M
Carpi
A
A
Marino
B
B
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects*; D001026:Coronary Artery Bypass; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D006801:Humans; D008297:Male; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012501:Saphenous Vein / Q000187:drug effects*; D012701:Serotonin / Q000494:pharmacology*; D013928:Thromboxane A2 / Q000494:pharmacology*; D013931:Thromboxanes / Q000494:pharmacology*; D014661:Vasoconstriction / Q000187:drug effects
D001095:Arachidonic Acids; D011450:Prostaglandin Endoperoxides, Synthetic; D013931:Thromboxanes; D016718:Arachidonic Acid; D012701:Serotonin; D013928:Thromboxane A2